19-Hydroxybufalin

CAS No. 39844-86-5

19-Hydroxybufalin( —— )

Catalog No. M24360 CAS No. 39844-86-5

19-Hydroxybufalin is a natural product, inhibits epithelial-mesenchymal transition and attenuates the migration and invasion of PC3 cells.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 314 In Stock
5MG 312 In Stock
10MG 462 In Stock
25MG 755 In Stock
50MG 1014 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    19-Hydroxybufalin
  • Note
    Research use only, not for human use.
  • Brief Description
    19-Hydroxybufalin is a natural product, inhibits epithelial-mesenchymal transition and attenuates the migration and invasion of PC3 cells.
  • Description
    19-Hydroxybufalin is a natural product, inhibits epithelial-mesenchymal transition and attenuates the migration and invasion of PC3 cells.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    39844-86-5
  • Formula Weight
    402.52
  • Molecular Formula
    C24H34O5
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:100 mg/mL (248.43 mM; Need ultrasonic)
  • SMILES
    C[C@@](CC[C@@H]([C@H]1CC2)[C@@](CO)(CC3)[C@H]2C[C@H]3O)([C@H](CC2)C(C=C3)=COC3=O)[C@@]12O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • 2-Decyltetradecanol

    2-Decyltetradecanol (2-Decyl-1-tetradecanol) is an initiator for the synthesis of demulsifiers.

  • ms48107

    MS48107 is a potent and selective positive allosteric modulator of G protein-coupled receptor 68 (GPR68). It is selective for GPR68 over the closely related proton GPCRs, neurotransmitter transporters, and hERG ion channels. It can readily cross the blood-brain barrier (BBB) in mice.

  • pep2-EVKI

    Inhibitor peptide that selectively disrupts binding of the AMPA receptor subunit GluA2 (at the C-terminal PDZ site) to protein interacting with C kinase (PICK1). Does not affect binding of GluA2 to GRIP or ABP and does not increase AMPA current amplitude or affect long term depression (LTD).